Inclusion and reporting of sex, gender, and race/ethnicity in randomized controlled trials of nonpharmacological treatments for alcohol use disorder: A meta-epidemiologic review

被引:13
|
作者
Schick, Melissa R. [1 ]
Nalven, Tessa [1 ]
Lynch-Gadaleta, Blaine [1 ]
Hostetler, Katherine L. [1 ]
Crawford, Michael C. [1 ]
Spillane, Nichea S. [1 ]
机构
[1] Univ Rhode Isl, Dept Psychol, PATHS Lab, Kingston, RI 02881 USA
来源
基金
美国国家卫生研究院;
关键词
alcohol use disorder; demographics; diversity; inclusion; meta-epidemiologic review; AFRICAN-AMERICANS; RACIAL INEQUITIES; RACE; METAANALYSIS; ABSTINENCE; DIVERSITY; MEDICINE; CARE;
D O I
10.1111/acer.14850
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Alcohol use disorders (AUDs) are among the most prevalent behavioral and mental health diagnoses. Individuals with an AUD are at increased risk for numerous consequences across their social, health, and psychological functioning. Research suggests that differences may exist in the prevalence and consequences of AUD and in the efficacy of AUD treatment across demographic characteristics (i.e., sex/gender and race/ethnicity). This meta-epidemiologic review examined the inclusion of diverse groups (sex/gender and race/ethnicity) in published randomized controlled trials of nonpharmacological treatments for AUD since 1994, following passage of the National Institutes of Health Revitalization Act of 1993. We systematically searched databases following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement criteria. The initial search strategy yielded 7931 articles. After excluding ineligible articles, 155 were included in the present review for synthesis. Of the articles included in this review, only 57 (36.8%) fully reported on both their sample's sex/gender and racial/ethnic breakdown. Of the total sample, seven articles specifically examined one racial/ethnic group and 32 specifically examined one sex/gender group. Six articles (3.9%) reported no information regarding the racial/ethnic breakdown of their sample and five articles (3.2%) reported no information regarding the sex/gender breakdown of their participants. Only two articles (1.3%) reported on subgroup analyses that examined differences in treatment outcomes by both sex/gender and race/ethnicity, despite guidelines set forth by NIH. Only 46 articles (29.7%) described the failure to include diverse sex/gender or racial/ethnic groups or concerns about the generalizability of study findings given their sample's sex/gender or racial/ethnic composition as methodological limitations. These results indicate that substantial efforts must be put forth by the scientific community to ensure the inclusion, analysis, and reporting of data focused on women/females and members of minoritized racial/ethnic groups.
引用
收藏
页码:1154 / 1165
页数:12
相关论文
共 43 条
  • [31] Group treatment for substance use disorder in adults: A systematic review and meta-analysis of randomized-controlled trials
    Lo Coco, Gianluca
    Melchiori, Francesco
    Oieni, Veronica
    Infurna, Maria Rita
    Strauss, Bernhard
    Schwartze, Dominique
    Rosendahl, Jenny
    Gullo, Salvatore
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 99 : 104 - 116
  • [32] Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials
    Iovieno, Nadia
    Tedeschini, Enrico
    Bentley, Kate H.
    Evins, A. Eden
    Papakostas, George I.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (08) : 1144 - 1151
  • [33] Sex, Race, and Age Differences in Cardiovascular Outcomes in Implantable Cardioverter-Defibrillator Randomized Controlled Trials: A Systematic Review and Meta-analysis
    Syed, Mohammad K.
    Sheikh, Hassan I.
    Mckay, Bradley
    Tseng, Nicholas
    Pakosh, Maureen
    Caterini, Jessica E.
    Sharma, Abhinav
    Colella, Tracey J. F.
    Konieczny, Kaja M.
    Connelly, Kim A.
    Graham, Michelle M.
    McDonald, Michael
    Banks, Laura
    Randhawa, Varinder Kaur
    CJC OPEN, 2021, 3 (12) : S209 - S217
  • [34] Cognitive-behavioral therapy and buprenorphine for opioid use disorder: A systematic review and meta-analysis of randomized controlled trials
    Gregory Jr, Virgil Lee
    Bartlett Ellis, Rebecca J.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (05): : 520 - 530
  • [35] Letter to the Editors regarding 'Efficacy of psychosocial interventions to reduce alcohol use in comorbid alcohol use disorder and alcohol-related liver disease: a systematic review of randomized controlled trials'
    Wei, Lien-Chung
    ALCOHOL AND ALCOHOLISM, 2024, 59 (02):
  • [36] Response to Letter to the Editors regarding 'Efficacy of psychosocial interventions to reduce alcohol use in comorbid alcohol use disorder and alcohol-related liver disease: a systematic review of randomized controlled trials'
    Hemrage, Sofia
    Brobbin, Eileen
    Deluca, Paolo
    Drummond, Colin
    ALCOHOL AND ALCOHOLISM, 2024, 59 (02):
  • [37] ANTIDEPRESSANT TREATMENT OF MDD IN PATIENTS WITH COMORBID ALCOHOL USE DISORDER: A META-ANALYSIS OF RANDOMIZED PLACEBO-CONTROLLED TRIALS WITH DISCUSSION OF PEDIATRIC IMPLICATIONS
    Johnson, Isaac N. S.
    Shovestul, Bridget J.
    Niciu, Mark J.
    Li, Fenghua
    Bloch, Michael H.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S166 - S166
  • [38] Systemic biases promoting the under-inclusion of marginalized groups in randomized controlled trials for co-occurring alcohol use and posttraumatic stress disorder: an intersectional analysis
    Reid, Mallet R.
    Buchanan, Nicole T.
    JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE, 2024,
  • [39] Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials
    Bakouni, Hamzah
    Sharafi, Heidar
    Bahremand, Arash
    Drouin, Sarah
    Ziegler, Daniela
    Bach, Paxton
    Le Foll, Bernard
    Schutz, Christian G.
    Tardelli, Vitor
    Ezard, Nadine
    Siefried, Krista
    Jutras-Aswad, Didier
    DRUG AND ALCOHOL DEPENDENCE, 2023, 253
  • [40] Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials
    Sharafi, Heidar
    Bakouni, Hamzah
    McAnulty, Christina
    Drouin, Sarah
    Coronado-Montoya, Stephanie
    Bahremand, Arash
    Bach, Paxton
    Ezard, Nadine
    Le Foll, Bernard
    Schutz, Christian G.
    Siefried, Krista J.
    Tardelli, Vitor S.
    Ziegler, Daniela
    Jutras-Aswad, Didier
    ADDICTION, 2024, 119 (02) : 211 - 224